乌龙制药(URGN)发布Q2财报,2025财年前六月累计收入4446.90万美元,去年同期累计收入为4062.90万美元,同比增长9.45%。2025财年前六月累计净亏损9378.30万美元,去年同期累计净亏损为6568.90万美元,同比扩大42.77%。本财年累计基本每股收益为-1.97美元,去年同期为-1.69美元。公司所属行业为制药。【公司信息】乌龙制药有限公司于2004年4月以以色列国法律...
Source Link乌龙制药(URGN)发布Q2财报,2025财年前六月累计收入4446.90万美元,去年同期累计收入为4062.90万美元,同比增长9.45%。2025财年前六月累计净亏损9378.30万美元,去年同期累计净亏损为6568.90万美元,同比扩大42.77%。本财年累计基本每股收益为-1.97美元,去年同期为-1.69美元。公司所属行业为制药。【公司信息】乌龙制药有限公司于2004年4月以以色列国法律...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.